These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 2978954)

  • 1. [Evidence for the existence of a positive feedback of the degree of expansion of the circulating volume, atrial distension and atrial natriuretic peptide in dialyzed uremic patients].
    Cannella G; Assanelli D; Ghielmi S; Gaggiotti M; Sandrini M; Poiesi C; Cuminetti S; Chiari E; Maiorca R
    Ann Ital Med Int; 1988; 3(2):103-10. PubMed ID: 2978954
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of atrial natriuretic factor on the hematocrit of patients in chronic hemodialysis].
    Burnier M; Porchet M; Waeber B; Wauters JP; Brunner HR
    Schweiz Med Wochenschr; 1987 Dec; 117(49):1953-6. PubMed ID: 2962284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma concentration of atrial natriuretic polypeptide in chronic hemodialysis patients.
    Yamamoto Y; Higa T; Kitamura K; Tanaka K; Kangawa K; Matsuo H
    Regul Pept Suppl; 1985; 4():110-2. PubMed ID: 2932774
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of beta-adrenergic blockade on the changes in atrial natriuretic factor induced by acute volume depletion.
    Sala C; Mangiarotti R; Pierini A; Badalamenti S; Pulazzini E; Morganti A; Zanchetti A
    J Hypertens Suppl; 1991 Dec; 9(6):S388-9. PubMed ID: 1687876
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasma human brain natriuretic peptide in chronic renal failure.
    Akiba T; Tachibana K; Togashi K; Hiroe M; Marumo F
    Clin Nephrol; 1995 Nov; 44 Suppl 1():S61-4. PubMed ID: 8608666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma levels of atrial natriuretic peptide in chronically dialyzed patients.
    Deray G; Maistre G; Basset JY; Cacoub P; Carayon A; Anouar M; Baumelou A; Legrand JC; Ancri D; Jacobs C
    Kidney Int Suppl; 1988 Sep; 25():S86-8. PubMed ID: 2972869
    [No Abstract]   [Full Text] [Related]  

  • 7. Differential regulation of brain and atrial natriuretic peptides in hemodialysis patients.
    Kohse KP; Feifel K; Mayer-Wehrstein R
    Clin Nephrol; 1993 Aug; 40(2):83-90. PubMed ID: 8222377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Variations of atrial natriuretic peptide in hemodialysis].
    Sagliaschi G; Angelitti AG; Del Vecchio P; Frassanito ML; Scaccia A; Leonetti G; Pace V
    Riv Eur Sci Med Farmacol; 1993; 15(5-6):219-21. PubMed ID: 7761674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal rhythmic oscillations of atrial natriuretic peptide and brain natriuretic peptide in chronic renal failure.
    Pedersen EB; Bacevicius E; Bech JN; Solling K; Pedersen HB
    Clin Sci (Lond); 2006 Apr; 110(4):491-501. PubMed ID: 16396628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma concentrations of natriuretic peptides in patients on hemodialysis.
    Takahashi M; Nagake Y; Ichikawa H; Kawabata K; Nakazono H; Hirata K; Ogura T; Makino H
    Res Commun Mol Pathol Pharmacol; 1996 Apr; 92(1):19-30. PubMed ID: 8733825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Volume and pressure relations of atrial natriuretic peptide].
    Machraoui A; Farag O; Jäger D; Lemke B; von Dryander S; Voss B; Wiebe V; Barmeyer J
    Z Kardiol; 1991; 80 Suppl 8():89-90. PubMed ID: 1839108
    [No Abstract]   [Full Text] [Related]  

  • 12. Central blood volume, atrial natriuretic peptide and intermittent hemodialysis.
    Wallin CJ; Rossi P; Jacobson SH; Leksell LG
    Scand J Urol Nephrol; 2004; 38(1):78-84. PubMed ID: 15204432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urotensin II in end-stage renal disease: an inverse correlate of sympathetic function and cardiac natriuretic peptides.
    Mallamaci F; Cutrupi S; Pizzini P; Tripepi G; Zoccali C
    J Nephrol; 2005; 18(6):727-32. PubMed ID: 16358231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of B-type natriuretic peptide to assess volume status in dialysis patients.
    Codognotto M; Piccoli A
    Am Heart J; 2007 Nov; 154(5):e31. PubMed ID: 17967574
    [No Abstract]   [Full Text] [Related]  

  • 15. Atrial natriuretic peptide release and volume regulation following kidney transplantation.
    Zuber M; Kiowski W; Huser B; Erne P; Bühler FR; Thiel G
    Clin Nephrol; 1993 Aug; 40(2):91-5. PubMed ID: 8222378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response of vasoactive substances to reduction of blood volume during hemodialysis in hypotensive patients.
    Heintz B; Reiners K; Gladziwa U; Kirsten R; Nelson K; Wieland D; Riehl J; Mann H; Sieberth HG
    Clin Nephrol; 1993 Apr; 39(4):198-204. PubMed ID: 8491049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal effects of atrial natriuretic factor and control of its secretion in various diseases.
    Ardaillou R; Dussaule JC; Michel C; Chansel D; Ardaillou N; Kanfer A; Grimaldi A; Mignon F
    Adv Nephrol Necker Hosp; 1990; 19():145-68. PubMed ID: 2154079
    [No Abstract]   [Full Text] [Related]  

  • 18. Diagnostic, prognostic, and therapeutic implications of brain natriuretic peptide in dialysis and nondialysis-dependent chronic renal failure.
    Mark PB; Petrie CJ; Jardine AG
    Semin Dial; 2007; 20(1):40-9. PubMed ID: 17244121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Is there a clinical indication for the determination of atrial natriuretic peptide?].
    Reiss U; Stimpel M
    Schweiz Rundsch Med Prax; 1993 Jul; 82(27-28):755-8. PubMed ID: 8346382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Arterial hypertension in patients on chronic hemodialysis].
    Zogović J; Mladenović Lj
    Srp Arh Celok Lek; 1996; 124(9-10):246-50. PubMed ID: 9102857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.